Dementia in parkinson's disease: Usefulness of the pill questionnaire

Movement Disorders

Volumn 28, Issue 13, 2013, Pages 1832-1837

  Martinez Martin, Pablo ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Activities of daily living; Dementia; Parkinson's disease; Pill Questionnaire; Screening

Indexed keywords

AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL IMPRESSION OF SEVERITY INDEX; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DEMENTIA; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBSERVATIONAL STUDY; PARKINSON DISEASE; PILL QUESTIONNAIRE; PREDICTIVE VALUE; PRIORITY JOURNAL; SCOPA MOTOR SUBSCALE; SENSITIVITY AND SPECIFICITY; TASK PERFORMANCE;

ACTIVITIES OF DAILY LIVING; DEMENTIA; PARKINSON'S DISEASE; PILL QUESTIONNAIRE; SCREENING;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DEMENTIA; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVATION; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84887625869     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25649     Document Type: Article

References (25)

1. Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004;127:550-560.
2. Barone P, Aarsland D, Burn D, Emre M, Kulisevsky J, Weintraub D. Cognitive impairment in nondemented Parkinson's disease. Mov Disord 2011;26:2483-2495.
3. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003;60:387-392.
4. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008;23:837-844.
5. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007;22:1689-1707.
6. Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 2007;22:2314-2324.
7. Reginold W, Armstrong MJ, Duff-Canning S, et al. The Pill Questionnaire in a nondemented Parkinson's disease population. Mov Disord 2012;27:1308-1311.
8. Christ JBM, Berger MF, Riedl E, et al. How precise are activities of daily living scales for the diagnosis of Parkinson's disease dementia? A pilot study. Parkinsonism Relat Disord 2013;19:371-374.
9. Martinez-Martin P, Frades-Payo B, Aguera-Ortiz L, Ayuga-Martinez A. A short Scale for Evaluation of Neuropsychiatric Disorders in Parkinson's Disease: first psychometric approach. J Neurol 2012;259:2299-2308.
10. Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet 2009;373:2055-2066.
11. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17:427-442.
12. Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ, de Pedro J, on behalf of the Spanish-American Longitudinal PD Patient Study Group. The Clinical Impression of Severity Index for Parkinson's disease: international validation study. Mov Disord 2009;24:211-217.
13. Martinez-Martin P, Benito-Leon J, Burguera JA, et al. The SCOPA-Motor Scale for assessment of Parkinson's disease is a consistent and valid measure. J Clin Epidemiol 2005;58:674-679.
14. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
15. Grupo de Estudio de Neurologia de la Conducta y Demencia-Sociedad Espanola de Neurologia. Guias en Demencias: Conceptos, Criterios y Recomendaciones Para el Estudio del Paciente con Demencia. Barcelona, Spain: Masson; 2000.
16. McKahnn GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:263-269.
17. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649-2653.
18. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
20. Aarsland D, Kurz MW. The epidemiology of dementia associated with Parkinson's disease. Brain Pathol 2010;20:633-639.
21. Dujardin K, Dubois B, Tison F, et al. Parkinson's disease dementia can be easily detected in routine clinical practice. Mov Disord 2010;25:2769-2776.
22. Martinez-Martin P, Falup-Pecurariu C, Rodriguez-Blazquez C, et al. Dementia associated with Parkinson's disease: applying the Movement Disorder Society Task Force criteria. Parkinsonism Relat Disord 2011;17:621-624.
23. Di Battista ME, Giustini P, Bernardi S, Stirpe P, Vanacore N, Meco G. A simplified algorithm may lead to overestimate dementia in PD. A clinical and epidemiological study using criteria for PD-D proposed by the Movement Disorders Task Force. J Neural Transm 2011;118:1609-1612.
24. Barton B, Grabli D, Bernard B, et al. Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia. Mov Disord 2012;27:248-253.
25. Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Ray Chaudhuri K; on behalf of the NMSS Validation Group. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Mov Disord 2011;26:399-406.